Table 4.
Unadjusted point estimatea | |||
---|---|---|---|
Covariates | Point estimate | 95% CI | P valuea |
Race(ref = other) | NA | NA | NAa |
Height (cm) | 0.98 | 0.88,1.10 | 0.74 |
Weight (kg) | 0.88 | 0.68,1.15 | 0.36 |
BSA | NA | NA | NA a |
BMI | 0.86 | 0.63,1.18 | 0.34 |
Temperature in arrival (C) | 0.43 | 0.12,1.49 | 0.18 |
Respiratory rate | 1.002 | 0.93,1.08 | 0.96 |
Heart rate | 1.07 | 0.99,1.14 | 0.08 |
Total dose levalbuterol given in ED and hospital (mg) | 2.001 | 0.901,4.44 | 0.09 |
Levalbuterol doses | 1.55 | 0.94,2.56 | 0.09 |
Total dose of albuterol in ED and hospital (mg) | 0.997 | 0.99,1.01 | 0.66 |
Albuterol doses | 0.994 | 0.97,1.02 | 0.66 |
Levalbuterol plus albuterol doses | 0.995 | 0.97,1.02 | 0.70 |
Beta agonist doses/time | 2.38 | 0.99,5.75 | 0.053 |
Number of chronic asthma control medications | 0.91 | 0.40,2.07 | 0.81 |
Number of days of illness prior to presentation | 0.47 | 0.18,1.25 | 0.13 |
Use albuterol at home(ref = no) | 0.15 | 0.017,1.31 | 0.08 |
Use levalbuterol at home(ref = no) | NA | NA | NAa |
History of diagnosed asthma(ref = no) | 0.59 | 0.11,3.15 | 0.54 |
History of documented SVT(ref = no) | NA | NA | NAa |
Family history of arrhythmia(ref = no) | NA | NA | NAa |
History of CHD(ref = no) | 1.62 | 0.14,18.63 | 0.70 |
Note: conditional logistic regression is conducted to evaluate the likelihood of having SVT.
The model was not converged due to insufficient sample size of case.